{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:05:58Z","timestamp":1781629558502,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Defense Malaria Assistance Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Identifying effective malaria elimination strategies for remote regions and highly mobile populations in Southeast Asia is challenging given limited resources. In this clinical trial, two malaria elimination strategies were evaluated in partnership with the Royal Cambodian Armed Forces - monthly malaria prophylaxis (MMP) and focused screening and treatment (FSAT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eight military cohorts (1,050 volunteers total) along the Cambodian-Thai border were randomly assigned to three months of either MMP or FSAT (four cohorts in each treatment arm) with monthly malaria testing for six months. Cohorts were further randomly assigned to receive either permethrin treated (ITU) or sham-treated clothing (sITU). Volunteers in MMP cohort were given three monthly three-day doses dihydroartemisinin-piperaquine (DP) along with a \u2018universal\u2019 low-dose weekly regimen of 22.5\u00a0mg primaquine for 12 weeks, intended for use regardless of body weight or G6PD status. Volunteers in FSAT cohort were treated with appropriate first-line antimalarials if they tested positive for malaria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      (\n                      <jats:italic>Pf<\/jats:italic>\n                      ) positivity in MMP cohorts was reduced by 90% (10% at enrollment to 1% at six months; absolute risk reduction (ARR) 9%) at 6 months. However, 32% of\n                      <jats:italic>Pf<\/jats:italic>\n                      cases treated with DP as MMP at baseline recrudesced, requiring rescue treatment at 1 month with artesunate-mefloquine.\n                      <jats:italic>Pf<\/jats:italic>\n                      positivity in FSAT cohorts declined 66% over six months (7.6% to 2.7%; ARR 4.9%). MMP reduced\n                      <jats:italic>P. vivax<\/jats:italic>\n                      (\n                      <jats:italic>Pv<\/jats:italic>\n                      ) positivity from 9% to 0% at three months, but\n                      <jats:italic>Pv<\/jats:italic>\n                      rebounded to 6.7% at six months. FSAT failed to significantly reduce\n                      <jats:italic>Pv<\/jats:italic>\n                      positivity during the study. The 22.5\u00a0mg weekly primaquine MMP regimen was safe, even for the 15% of volunteers with G6PD-deficiency. Those wearing ITU had additional\n                      <jats:italic>Pv<\/jats:italic>\n                      parasitemia reductions compared to sITU in the FSAT but not MMP cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      MMP was safe, and superior to FSAT, suggesting greater utility to achieve malaria elimination in Cambodia. Low dose (22.5\u00a0mg) weekly primaquine was a safe adjunct in this setting, even for those with G6PD-deficiency. Permethrin-treated clothing further reduced\n                      <jats:italic>Pv<\/jats:italic>\n                      parasitemia for FSAT but not MMP. We observed that MMP may be more easily scaled to eliminate malaria and that the military may provide substantial support for regional elimination efforts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      The study was registered on\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/<\/jats:ext-link>\n                      on 13-01-2016 prior to enrollment (NCT02653898).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12207-4","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T02:03:50Z","timestamp":1765505030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating malaria elimination strategies among military forces in Cambodia: a multi-arm clinical trial comparing monthly prophylaxis and focused screening and treatment"],"prefix":"10.1186","volume":"26","author":[{"given":"Mariusz","family":"Wojnarski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidhartha","family":"Chaudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Threechada","family":"Boonchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathvicheth","family":"Bun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soklyda","family":"Chann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panita","family":"Gosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin","family":"Soveasna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokhun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nillawan","family":"Buathong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Ittiverakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabaithip","family":"Sriwichai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montri","family":"Arsanok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worachet","family":"Kuntawunginn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyaporn","family":"Saingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaiyaporn","family":"Chaisatit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alongkot","family":"Ponlawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyalak","family":"Fansiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattaraporn","family":"Vanachayangkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boonsong","family":"Jaichapor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muth","family":"Sinoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Char Meng","family":"Chuor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thay","family":"Kheangheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silas","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Spring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Rekol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lek","family":"Dysoley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong","family":"Saly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Livezey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica T.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prom","family":"Satharath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somethy","family":"Sok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"12207_CR1","doi-asserted-by":"publisher","first-page":"e93138","DOI":"10.1371\/journal.pone.0093138","volume":"9","author":"C Lon","year":"2014","unstructured":"Lon C, Manning JE, Vanachayangkul P, So M, Sea D, Se Y, Gosi P, Lanteri C, Chaorattanakawee S, Sriwichai S, et al. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in Northern cambodia: an open-label randomized trial. PLoS ONE. 2014;9:e93138.","journal-title":"PLoS ONE"},{"key":"12207_CR2","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Artemisinin resistance in Cambodia 1 study C: evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"12207_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","volume":"15","author":"MD Spring","year":"2015","unstructured":"Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, Se Y, Chann S, Ittiverakul M, Sia-ngam P, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in cambodia: an observational cohort study. Lancet Infect Dis. 2015;15:683\u201391.","journal-title":"Lancet Infect Dis"},{"key":"12207_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3201\/eid1405.071601","volume":"14","author":"C Wongsrichanalai","year":"2008","unstructured":"Wongsrichanalai C, Meshnick SR. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis. 2008;14:716\u20139.","journal-title":"Emerg Infect Dis"},{"key":"12207_CR5","unstructured":"Ph\u01b0\u01a1ng VT. New initiatives launched to end malaria in ASEAN. Vietnam. Hanoi. 2018."},{"key":"12207_CR6","unstructured":"Countries in WHO South-East Asia Region. renew commitment to eliminate malaria by 2030 [https:\/\/www.who.int\/southeastasia\/news\/detail\/05-05-2022-countries-in-who-south-east-asia-region-renew-commitment-to-eliminate-malaria-by-2030]"},{"key":"12207_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12936-022-04234-2","volume":"21","author":"S Sovannaroth","year":"2022","unstructured":"Sovannaroth S, Ngor P, Khy V, Dunn JC, Burbach MK, Peng S, Mak S, Siv K, Manzoni G, Guintran JO, et al. Accelerating malaria elimination in cambodia: an intensified approach for targeting at-risk populations. Malar J. 2022;21:209.","journal-title":"Malar J"},{"key":"12207_CR8","unstructured":"World Health Organization. World malaria report 2024. Geneva: World Health Organization; 2024."},{"key":"12207_CR9","unstructured":"World Health Organization. World malaria report 2020. Geneva: World Health Organization; 2020."},{"key":"12207_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, Smithuis FM, Hlaing TM, Tun KM, van der Pluijm RW, et al. The spread of artemisinin-resistant plasmodium falciparum in the greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491\u20137.","journal-title":"Lancet Infect Dis"},{"key":"12207_CR11","doi-asserted-by":"publisher","first-page":"363417","DOI":"10.1155\/2013\/363417","volume":"2013","author":"A Bhumiratana","year":"2013","unstructured":"Bhumiratana A, Intarapuk A, Sorosjinda-Nunthawarasilp P, Maneekan P, Koyadun S. Border malaria associated with multidrug resistance on Thailand-Myanmar and Thailand-Cambodia borders: transmission dynamic, vulnerability, and surveillance. Biomed Res Int. 2013;2013:363417.","journal-title":"Biomed Res Int"},{"key":"12207_CR12","first-page":"261","volume":"43","author":"P Wangroongsarb","year":"2012","unstructured":"Wangroongsarb P, Sudathip P, Satimai W. Characteristics and malaria prevalence of migrant populations in malaria-endemic areas along the Thai-Cambodian border. Southeast Asian J Trop Med Public Health. 2012;43:261\u20139.","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"Suppl 1","key":"12207_CR13","first-page":"201","volume":"44","author":"MD Bustos","year":"2013","unstructured":"Bustos MD, Wongsrichanalai C, Delacollette C, Burkholder B. Monitoring antimalarial drug efficacy in the greater Mekong subregion: an overview of in vivo results from 2008 to 2010. Southeast Asian J Trop Med Public Health. 2013;44(Suppl 1):201\u201330. discussion 306\u2009\u2013\u2009207.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"12207_CR14","first-page":"674","volume":"40","author":"C Delacollette","year":"2009","unstructured":"Delacollette C, D\u2019Souza C, Christophel E, Thimasarn K, Abdur R, Bell D, Dai TC, Gopinath D, Lu S, Mendoza R, et al. Malaria trends and challenges in the greater Mekong subregion. Southeast Asian J Trop Med Public Health. 2009;40:674\u201391.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"12207_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12936-019-2666-5","volume":"18","author":"SD Nofal","year":"2019","unstructured":"Nofal SD, Peto TJ, Adhikari B, Tripura R, Callery J, Bui TM, von Seidlein L, Pell C. How can interventions that target forest-goers be tailored to accelerate malaria elimination in the greater Mekong subregion? A systematic review of the qualitative literature. Malar J. 2019;18:32.","journal-title":"Malar J"},{"key":"12207_CR16","doi-asserted-by":"crossref","unstructured":"Schneider ZD, Shah MP, Boily MC, Busbee AL, Hwang J, Lindblade KA, Gutman JR. Mass drug administration to reduce malaria transmission: a systematic review and meta-analysis. Am J Trop Med Hyg. 2023.","DOI":"10.4269\/ajtmh.22-0766"},{"key":"12207_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"93","author":"G Newby","year":"2015","unstructured":"Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, Shanks GD, Slutsker L, Kachur SP, Wegbreit J, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125\u201334.","journal-title":"Am J Trop Med Hyg"},{"key":"12207_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1475-2875-13-51","volume":"13","author":"A Kondrashin","year":"2014","unstructured":"Kondrashin A, Baranova AM, Ashley EA, Recht J, White NJ, Sergiev VP. Mass primaquine treatment to eliminate Vivax malaria: lessons from the past. Malar J. 2014;13:51.","journal-title":"Malar J"},{"key":"12207_CR19","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1016\/S2214-109X(17)30220-6","volume":"5","author":"OJ Brady","year":"2017","unstructured":"Brady OJ, Slater HC, Pemberton-Ross P, Wenger E, Maude RJ, Ghani AC, Penny MA, Gerardin J, White LJ, Chitnis N, et al. Role of mass drug administration in elimination of plasmodium falciparum malaria: a consensus modelling study. Lancet Glob Health. 2017;5:e680\u20137.","journal-title":"Lancet Glob Health"},{"key":"12207_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12936-016-1460-x","volume":"15","author":"KM Searle","year":"2016","unstructured":"Searle KM, Hamapumbu H, Lubinda J, Shields TM, Pinchoff J, Kobayashi T, Stevenson JC, Bridges DJ, Larsen DA, Thuma PE, et al. Evaluation of the operational challenges in implementing reactive screen-and-treat and implications of reactive case detection strategies for malaria elimination in a region of low transmission in Southern Zambia. Malar J. 2016;15:412.","journal-title":"Malar J"},{"key":"12207_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12936-023-04670-8","volume":"22","author":"G Newby","year":"2023","unstructured":"Newby G, Cotter C, Roh ME, Harvard K, Bennett A, Hwang J, Chitnis N, Fine S, Stresman G, Chen I, et al. Testing and treatment for malaria elimination: a systematic review. Malar J. 2023;22:254.","journal-title":"Malar J"},{"key":"12207_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12936-019-3008-3","volume":"18","author":"N Sanann","year":"2019","unstructured":"Sanann N, Peto TJ, Tripura R, Callery JJ, Nguon C, Bui TM, Nofal SD, von Seidlein L, Lek D, Dondorp AM, et al. Forest work and its implications for malaria elimination: a qualitative study. Malar J. 2019;18:376.","journal-title":"Malar J"},{"key":"12207_CR23","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/infdis\/jiu655","volume":"211","author":"J Cook","year":"2015","unstructured":"Cook J, Xu W, Msellem M, Vonk M, Bergstrom B, Gosling R, Al-Mafazy AW, McElroy P, Molteni F, Abass AK, et al. Mass screening and treatment on the basis of results of a plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar. J Infect Dis. 2015;211:1476\u201383.","journal-title":"J Infect Dis"},{"key":"12207_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1475-2875-10-210","volume":"10","author":"SE Kern","year":"2011","unstructured":"Kern SE, Tiono AB, Makanga M, Gbadoe AD, Premji Z, Gaye O, Sagara I, Ubben D, Cousin M, Oladiran F, et al. Community screening and treatment of asymptomatic carriers of plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis. Malar J. 2011;10:210.","journal-title":"Malar J"},{"key":"12207_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12936-016-1333-3","volume":"15","author":"CA Scott","year":"2016","unstructured":"Scott CA, Yeshiwondim AK, Serda B, Guinovart C, Tesfay BH, Agmas A, Zeleke MT, Guesses GS, Ayenew AL, Workie WM, et al. Mass testing and treatment for malaria in low transmission areas in Amhara Region, Ethiopia. Malar J. 2016;15:305.","journal-title":"Malar J"},{"key":"12207_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1475-2875-5-63","volume":"5","author":"EW Kimani","year":"2006","unstructured":"Kimani EW, Vulule JM, Kuria IW, Mugisha F. Use of insecticide-treated clothes for personal protection against malaria: a community trial. Malar J. 2006;5:63.","journal-title":"Malar J"},{"key":"12207_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/clinids\/21.3.599","volume":"21","author":"J Soto","year":"1995","unstructured":"Soto J, Medina F, Dember N, Berman J. Efficacy of permethrin-impregnated uniforms in the prevention of malaria and leishmaniasis in Colombian soldiers. Clin Infect Dis. 1995;21:599\u2013602.","journal-title":"Clin Infect Dis"},{"key":"12207_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s13063-021-05801-9","volume":"22","author":"D Msellemu","year":"2021","unstructured":"Msellemu D, Ross A, Temu L, Moshi I, Hofer L, Mwanziva C, Kohi YM, Moore SJ. Effect of interventions to reduce malaria incidence among military personnel on active duty: study protocol for a cluster randomised controlled trial of the impact of etofenprox-treated uniforms, permethrin-treated uniforms and DEET insect repellent. Trials. 2021;22:825.","journal-title":"Trials"},{"key":"12207_CR29","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s13063-018-2931-x","volume":"19","author":"J Manning","year":"2018","unstructured":"Manning J, Lon C, Spring M, Wojnarski M, Somethy S, Chann S, Gosi P, Soveasna K, Sriwichai S, Kuntawunginn W, et al. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia. Trials. 2018;19:558.","journal-title":"Trials"},{"key":"12207_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0035-9203(99)90120-7","volume":"93","author":"G Snounou","year":"1999","unstructured":"Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S. Biased distribution of msp1 and msp2 allelic variants in plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg. 1999;93:369\u201374.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"12207_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0010-4825(03)00039-8","volume":"34","author":"MK Campbell","year":"2004","unstructured":"Campbell MK, Thomson S, Ramsay CR, MacLennan GS, Grimshaw JM. Sample size calculator for cluster randomized trials. Comput Biol Med. 2004;34:113\u201325.","journal-title":"Comput Biol Med"},{"key":"12207_CR32","doi-asserted-by":"crossref","unstructured":"Altman D. Practical statistics for medical research. Chapman & Hall; 1991.","DOI":"10.1201\/9780429258589"},{"key":"12207_CR33","doi-asserted-by":"publisher","first-page":"e1002224","DOI":"10.1371\/journal.pmed.1002224","volume":"14","author":"CS Chu","year":"2017","unstructured":"Chu CS, Bancone G, Moore KA, Win HH, Thitipanawan N, Po C, Chowwiwat N, Raksapraidee R, Wilairisak P, Phyo AP, et al. Haemolysis in G6PD heterozygous females treated with primaquine for plasmodium Vivax malaria: A nested cohort in a trial of radical curative regimens. PLoS Med. 2017;14:e1002224.","journal-title":"PLoS Med"},{"key":"12207_CR34","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1128\/AAC.00366-15","volume":"59","author":"S Chaorattanakawee","year":"2015","unstructured":"Chaorattanakawee S, Saunders DL, Sea D, Chanarat N, Yingyuen K, Sundrakes S, Saingam P, Buathong N, Sriwichai S, Chann S, et al. Ex vivo drug susceptibility testing and molecular profiling of clinical plasmodium falciparum isolates from Cambodia from 2008 to 2013 suggest emerging Piperaquine resistance. Antimicrob Agents Chemother. 2015;59:4631\u201343.","journal-title":"Antimicrob Agents Chemother"},{"key":"12207_CR35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12936-017-2034-2","volume":"16","author":"S Chaorattanakawee","year":"2017","unstructured":"Chaorattanakawee S, Lon C, Chann S, Thay KH, Kong N, You Y, Sundrakes S, Thamnurak C, Chattrakarn S, Praditpol C, et al. Measuring ex vivo drug susceptibility in plasmodium Vivax isolates from Cambodia. Malar J. 2017;16:392.","journal-title":"Malar J"},{"key":"12207_CR36","doi-asserted-by":"publisher","first-page":"ofz314","DOI":"10.1093\/ofid\/ofz314","volume":"6","author":"M Wojnarski","year":"2019","unstructured":"Wojnarski M, Lon C, Vanachayangkul P, Gosi P, Sok S, Rachmat A, Harrison D, Berjohn CM, Spring M, Chaoratanakawee S, et al. Atovaquone-Proguanil in combination with Artesunate to treat Multidrug-Resistant P. falciparum malaria in cambodia: an Open-Label randomized trial. Open Forum Infect Dis. 2019;6:ofz314.","journal-title":"Open Forum Infect Dis"},{"key":"12207_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1056\/NEJMc1403007","volume":"371","author":"DL Saunders","year":"2014","unstructured":"Saunders DL, Vanachayangkul P, Lon C, Program USAMMR, National Center for Parasitology E, Malaria C. Royal Cambodian armed F: Dihydroartemisinin-piperaquine failure in Cambodia. N Engl J Med. 2014;371:484\u20135.","journal-title":"N Engl J Med"},{"key":"12207_CR38","doi-asserted-by":"publisher","first-page":"e1002745","DOI":"10.1371\/journal.pmed.1002745","volume":"16","author":"L von Seidlein","year":"2019","unstructured":"von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, Pongvongsa T, Lwin KM, Keereecharoen L, Kajeechiwa L, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast asia: A cluster randomised trial. PLoS Med. 2019;16:e1002745.","journal-title":"PLoS Med"},{"key":"12207_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4269\/ajtmh.16-0208","volume":"95","author":"S Siv","year":"2016","unstructured":"Siv S, Roca-Feltrer A, Vinjamuri SB, Bouth DM, Lek D, Rashid MA, By NP, Popovici J, Huy R, Menard D. Plasmodium Vivax malaria in Cambodia. Am J Trop Med Hyg. 2016;95:97\u2013107.","journal-title":"Am J Trop Med Hyg"},{"key":"12207_CR40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/infdis\/jiv142","volume":"212","author":"JT Lin","year":"2015","unstructured":"Lin JT, Hathaway NJ, Saunders DL, Lon C, Balasubramanian S, Kharabora O, Gosi P, Sriwichai S, Kartchner L, Chuor CM, et al. Using amplicon deep sequencing to detect genetic signatures of plasmodium Vivax relapse. J Infect Dis. 2015;212:999\u20131008.","journal-title":"J Infect Dis"},{"key":"12207_CR41","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5694\/j.1326-5377.1984.tb104083.x","volume":"140","author":"TR Grimmond","year":"1984","unstructured":"Grimmond TR, Cameron AS. Primaquine-chloroquine prophylaxis against malaria in Southeast-Asian refugees entering South Australia. Med J Aust. 1984;140:322\u20135.","journal-title":"Med J Aust"},{"key":"12207_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12936-021-03886-w","volume":"20","author":"WR Taylor","year":"2021","unstructured":"Taylor WR, Hoglund RM, Peerawaranun P, Nguyen TN, Hien TT, Tarantola A, von Seidlein L, Tripura R, Peto TJ, Dondorp AM, et al. Development of weight and age-based dosing of daily primaquine for radical cure of Vivax malaria. Malar J. 2021;20:366.","journal-title":"Malar J"},{"key":"12207_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1802537","volume":"380","author":"A Llanos-Cuentas","year":"2019","unstructured":"Llanos-Cuentas A, Lacerda MVG, Hien TT, Velez ID, Namaik-Larp C, Chu CS, Villegas MF, Val F, Monteiro WM, Brito MAM, et al. Tafenoquine versus primaquine to prevent relapse of plasmodium Vivax malaria. N Engl J Med. 2019;380:229\u201341.","journal-title":"N Engl J Med"},{"key":"12207_CR44","doi-asserted-by":"publisher","first-page":"e0011522","DOI":"10.1371\/journal.pntd.0011522","volume":"17","author":"WRJ Taylor","year":"2023","unstructured":"Taylor WRJ, Meagher N, Ley B, Thriemer K, Bancone G, Satyagraha A, Assefa A, Chand K, Chau NH, Dhorda M, et al. Weekly primaquine for radical cure of patients with plasmodium Vivax malaria and glucose-6-phosphate dehydrogenase deficiency. PLoS Negl Trop Dis. 2023;17:e0011522.","journal-title":"PLoS Negl Trop Dis"},{"key":"12207_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4269\/ajtmh.1999.61.367","volume":"61","author":"DP Mason","year":"1999","unstructured":"Mason DP, McKenzie FE. Blood-stage dynamics and clinical implications of mixed plasmodium vivax-Plasmodium falciparum infections. Am J Trop Med Hyg. 1999;61:367\u201374.","journal-title":"Am J Trop Med Hyg"},{"key":"12207_CR46","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.pt.2018.07.001","volume":"34","author":"MJ Delves","year":"2018","unstructured":"Delves MJ, Angrisano F, Blagborough AM. Antimalarial Transmission-Blocking interventions: Past, Present, and future. Trends Parasitol. 2018;34:735\u201346.","journal-title":"Trends Parasitol"},{"key":"12207_CR47","doi-asserted-by":"publisher","first-page":"e0168702","DOI":"10.1371\/journal.pone.0168702","volume":"12","author":"JT Lin","year":"2017","unstructured":"Lin JT, Lon C, Spring MD, Sok S, Chann S, Ittiverakul M, Kuntawunginn W, My M, Thay K, Rahman R, et al. Single dose primaquine to reduce gametocyte carriage and plasmodium falciparum transmission in cambodia: an open-label randomized trial. PLoS ONE. 2017;12:e0168702.","journal-title":"PLoS ONE"},{"key":"12207_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pt.2014.02.004","volume":"30","author":"JT Lin","year":"2014","unstructured":"Lin JT, Saunders DL, Meshnick SR. The role of submicroscopic parasitemia in malaria transmission: what is the evidence? Trends Parasitol. 2014;30:183\u201390.","journal-title":"Trends Parasitol"},{"key":"12207_CR49","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.1128\/AAC.02667-14","volume":"58","author":"J Manning","year":"2014","unstructured":"Manning J, Vanachayangkul P, Lon C, Spring M, So M, Sea D, Se Y, Somethy S, Phann ST, Chann S, et al. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval. Antimicrob Agents Chemother. 2014;58:6056\u201367.","journal-title":"Antimicrob Agents Chemother"},{"key":"12207_CR50","doi-asserted-by":"publisher","first-page":"e0228207","DOI":"10.1371\/journal.pone.0228207","volume":"15","author":"B Wojnarski","year":"2020","unstructured":"Wojnarski B, Lon C, Sea D, Sok S, Sriwichai S, Chann S, Hom S, Boonchan T, Ly S, Sok C, et al. Evaluation of the carestart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia. PLoS ONE. 2020;15:e0228207.","journal-title":"PLoS ONE"},{"key":"12207_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","volume":"13","author":"NJ White","year":"2013","unstructured":"White NJ. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis. 2013;13:175\u201381.","journal-title":"Lancet Infect Dis"},{"key":"12207_CR52","doi-asserted-by":"crossref","unstructured":"Chhim S, Piola P, Housen T, Herbreteau V, Tol B. Malaria in Cambodia: a retrospective analysis of a changing epidemiology 2006\u20132019. Int J Environ Res Public Health. 2021;18.","DOI":"10.3390\/ijerph18041960"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12207-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12207-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12207-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:26:17Z","timestamp":1781627177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12207-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12207"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12207-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at the Walter Reed Army Institute of Research and the Cambodian National Ethics Committee on Human Research and conducted in a manner that adhered to the principles outlined in the Declaration of Helinski. Informed consent was obtained from all the participants and from the legal guardians of the participants who were below 16 years of age.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The views expressed in this article are those of the authors and do not reflect the official policy of the US Department of the Army, US Department of Defense, the US Government or the Royal Government of Cambodia.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}